Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

January 29, 2024

https://www.prnewswire.com/news-releases/anixa-biosciences-announces-participation-in-2024-neauxcancer-oncology-conference-302046213.html

Conference Investment Track spotlights promising and emerging biotech and healthcare companies advancing the field of oncology

SAN JOSE, Calif. , Jan. 29, 2024 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced its participation in the 2024 NeauxCancer Conference organized by the Cancer Advocacy Group of Louisiana (CAGLA), being held February 29 – March 2, 2024 in New Orleans. Anixa Chairman and CEO Dr. Amit Kumar will present and meet one-on-one with investors throughout the day on Friday, March 1st.

Read more at prnewswire.com

Related news for (ANIX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.